PMDAsafety guidance83% confidence
[ANZEN]PMDA Alert for Proper Use of Drugs: Serious hypocarnitinemia and hypoglycaemia in children treated with antibacterials with a pivoxil group (follow-up report) posted
Source: PMDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (ild) as adenotonsillar hypertrophy treatment protocols.
Regulatory Analysis
PMDA regulatory document relevant to this signal.
Supporting Context
- Therapeutic area
- ENT · Surgical Intervention
- Sub-indication
- Ild
Related signal: Feasibility Study on IRE System for Adenotonsillar Hypertrophy in Children